Reviving drugs with anti-stroke potential, minus side effects
In the 1990s, neuroscientists identified a class of drugs that showed promise in the area of stroke. NMDA receptor antagonists could limit damage to the brain in animal models of stroke. But one problem complicated testing ...
Feb 27, 2015
0
96